R. Somers

4.0k total citations
65 papers, 2.9k citations indexed

About

R. Somers is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, R. Somers has authored 65 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pathology and Forensic Medicine, 34 papers in Pulmonary and Respiratory Medicine and 22 papers in Oncology. Recurrent topics in R. Somers's work include Lymphoma Diagnosis and Treatment (33 papers), Lung Cancer Treatments and Mutations (18 papers) and Sarcoma Diagnosis and Treatment (15 papers). R. Somers is often cited by papers focused on Lymphoma Diagnosis and Treatment (33 papers), Lung Cancer Treatments and Mutations (18 papers) and Sarcoma Diagnosis and Treatment (15 papers). R. Somers collaborates with scholars based in Netherlands, France and Belgium. R. Somers's co-authors include Flora E. van Leeuwen, P. van Heerde, Anton Hagenbeek, M. Henry‐Amar, Alexandra W. van den Belt‐Dusebout, Willem J. Klokman, J. M. V. Burgers, Patrice Carde, M Tubiana and D. Thomas and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and Neurology.

In The Last Decade

R. Somers

62 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Somers Netherlands 26 1.7k 1.2k 1.1k 524 486 65 2.9k
E.M. Noordijk Netherlands 26 1.9k 1.1× 742 0.6× 1.3k 1.2× 600 1.1× 494 1.0× 50 2.8k
Lillian M. Fuller United States 37 2.9k 1.7× 1000 0.8× 1.7k 1.5× 908 1.7× 667 1.4× 101 4.3k
Paul Smith United Kingdom 24 1.9k 1.1× 780 0.6× 1.4k 1.2× 742 1.4× 445 0.9× 66 3.5k
D Sarrazin France 31 1.5k 0.9× 968 0.8× 1.4k 1.3× 268 0.5× 962 2.0× 77 4.1k
Mars B. vanʼt Veer Netherlands 24 1.7k 1.0× 806 0.6× 1.0k 0.9× 437 0.8× 207 0.4× 59 3.8k
G P Canellos United States 23 2.1k 1.3× 728 0.6× 1.2k 1.0× 806 1.5× 222 0.5× 33 2.8k
G. Vaughan Hudson United Kingdom 33 3.1k 1.8× 915 0.7× 2.0k 1.7× 896 1.7× 285 0.6× 66 4.0k
Alberto Banfi Italy 21 1.9k 1.1× 590 0.5× 1.6k 1.4× 328 0.6× 1.1k 2.2× 48 3.8k
José Thomas Belgium 38 3.3k 1.9× 1.2k 1.0× 1.5k 1.3× 1.2k 2.3× 243 0.5× 77 4.3k
R S Cox United States 20 1.0k 0.6× 747 0.6× 712 0.6× 334 0.6× 209 0.4× 25 2.1k

Countries citing papers authored by R. Somers

Since Specialization
Citations

This map shows the geographic impact of R. Somers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Somers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Somers more than expected).

Fields of papers citing papers by R. Somers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Somers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Somers. The network helps show where R. Somers may publish in the future.

Co-authorship network of co-authors of R. Somers

This figure shows the co-authorship network connecting the top 25 collaborators of R. Somers. A scholar is included among the top collaborators of R. Somers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Somers. R. Somers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Somers, R., et al.. (2001). Adult height and age at menarche in childhood cancer survivors. European Journal of Cancer. 37(5). 605–612. 43 indexed citations
2.
Leeuwen, Flora E. van, Willem J. Klokman, Mars B. vanʼt Veer, et al.. (2000). Long-Term Risk of Second Malignancy in Survivors of Hodgkin’s Disease Treated During Adolescence or Young Adulthood. Journal of Clinical Oncology. 18(3). 487–487. 302 indexed citations
3.
Guglielmi, Cesare, F. Gómez, Thierry Philip, et al.. (1998). Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial.. Journal of Clinical Oncology. 16(10). 3264–3269. 115 indexed citations
4.
Balm, Alfons J. M., Frits van Coevorden, K. E. Bos, et al.. (1995). Report of a symposium on diagnosis and treatment of adult soft tissue sarcomas in the head and neck. European Journal of Surgical Oncology. 21(3). 287–289. 23 indexed citations
5.
6.
Leeuwen, Flora E. van, Willem J. Klokman, Anton Hagenbeek, et al.. (1994). Second cancer risk following Hodgkin's disease: a 20-year follow-up study.. Journal of Clinical Oncology. 12(2). 312–325. 345 indexed citations
7.
8.
Kerbrat, Pierre, R. Somers, Jaap Verweij, et al.. (1993). Phase II study of fotemustine in advanced soft tissue sarcomas. European Journal of Cancer. 29(1). 143–144. 3 indexed citations
9.
Leeuwen, Flora E. van, et al.. (1993). Second cancer risk following testicular cancer: a follow-up study of 1,909 patients.. Journal of Clinical Oncology. 11(3). 415–424. 181 indexed citations
10.
Taal, Babs G., P. van Heerde, & R. Somers. (1993). Isolated primary oesophageal involvement by lymphoma: a rare cause of dysphagia: two case histories and a review of other published data.. Gut. 34(7). 994–998. 31 indexed citations
11.
Cosset, Jean‐Marc, M. Henry‐Amar, J.H. Meerwaldt, et al.. (1992). The EORTC trials for limited stage Hodgkin's disease. European Journal of Cancer. 28(11). 1847–1850. 47 indexed citations
12.
Thomas, José, Ben de Pauw, Anton Hagenbeek, et al.. (1992). Phase II study of cytarabine in Hodgkin's disease. European Journal of Cancer. 28(4-5). 857–859. 3 indexed citations
13.
Verweij, Jaap, A.T. van Oosterom, R. Somers, et al.. (1992). Chemotherapy in the multidisciplinary approach to soft tissue sarcomas. Annals of Oncology. 3. S75–S80. 18 indexed citations
14.
Wagener, D. J. Th., R. Somers, Armando Santoro, et al.. (1991). Phase II study of nimustine in metastatic soft tissue sarcoma. European Journal of Cancer and Clinical Oncology. 27(12). 1604–1605. 6 indexed citations
15.
Henry‐Amar, M., Samuel Friedman, Marcel Hayat, et al.. (1991). Erythrocyte Sedimentation Rate Predicts Early Relapse and Survival in Early-Stage Hodgkin Disease. Annals of Internal Medicine. 114(5). 361–365. 67 indexed citations
16.
Henry‐Amar, M., M. Hayat, J.H. Meerwaldt, et al.. (1990). Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocols. International Journal of Radiation Oncology*Biology*Physics. 19(5). 1155–1157. 80 indexed citations
17.
Leeuwen, Flora E. van, R. Somers, B.G. Taal, et al.. (1989). Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease.. Journal of Clinical Oncology. 7(8). 1046–1058. 118 indexed citations
18.
Tirelli, Umberto, Vittorina Zagonel, Diego Serraino, et al.. (1988). Non Hodgkin's Lymphomas in 137 patients aged 70 years or older: a retrospective EORTC Lymphoma Group Study. Journal of Clinical Oncology. 11. 1708–1713. 4 indexed citations
19.
Mouridsen, Henning T., Lars Bastholt, R. Somers, et al.. (1987). Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC soft tissue and bone sarcoma group. European Journal of Cancer and Clinical Oncology. 23(10). 1477–1483. 122 indexed citations
20.
Tubiana, M, Patrice Carde, J. M. V. Burgers, et al.. (1986). Prognostic factors in non-Hodgkin's lymphoma. International Journal of Radiation Oncology*Biology*Physics. 12(4). 503–514. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E.M. Noordijk Breakdown of academic impact, for papers by Lillian M. Fuller Breakdown of academic impact, for papers by Paul Smith Breakdown of academic impact, for papers by D Sarrazin Breakdown of academic impact, for papers by Mars B. vanʼt Veer Breakdown of academic impact, for papers by G P Canellos Breakdown of academic impact, for papers by G. Vaughan Hudson Breakdown of academic impact, for papers by Alberto Banfi Breakdown of academic impact, for papers by José Thomas Breakdown of academic impact, for papers by R S Cox
Rankless by CCL
2026